clinical trial · NCT07757152
Phase I Clinical Study of ZL-65 Tablet in Healthy Adult Participants in China
Chengdu Zenitar Biomedical Technology Co., Ltd·phase1·recruiting·n = 108
Healthy Participants StudyThis group of participants take ZL-65 tabletThis group of participants take ZL-65 placebo tablet
brief summary
To evaluate the tolerability and safety of a single oral dose of ZL-65 tablets in healthy adult trial participants through dose escalation; and to preliminarily assess the pharmacokinetic and pharmacodynamic characteristics of a single oral dose of ZL-65 tablets.Exploring the impact of food intake on the PK of orally administered ZL-65 tablets in healthy adult trial participants.
started
Jul 23, 2026
primary completion
Jul 30, 2027
completion
Dec 30, 2027
last updated
Aug 11, 2026
official title
Phase I Clinical Study of ZL-65 Tablet in Healthy Adult Participants in China: Randomized, Double-blind, Placebo-controlled, Single/Multiple Oral Dose Escalation for Safety Tolerability, Pharmacokinetics, Preliminary Pharmacodynamics, and Food Effect
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol